Successful Treatment of Severe Refractory Atopic Dermatitis with Efalizumab

November 2006 | Volume 5 | Issue 10 | Case Reports | 994 | Copyright © November 2006

Arta Farshidi BS, Parrish Sadeghi MD

Despite multiple therapeutic modalities, treatment of atopic dermatitis with its chronic, relapsing nature remains a challenge. Chronic use of standard therapies is associated with variable efficacy and potential side effects. Targeted therapeutic approaches using biologic agents may prove to be a novel alternative. We present a case of severe recalcitrant atopic dermatitis successfully treated with efalizumab.